Home/Filings/4/0001181431-15-001720
4//SEC Filing

Zosano Pharma Corp 4

Accession 0001181431-15-001720

CIK 0001587221operating

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 1:32 PM ET

Size

22.9 KB

Accession

0001181431-15-001720

Insider Transaction Report

Form 4
Period: 2015-01-30
Transactions
  • Conversion

    Common Stock

    2015-01-30$9.35/sh+341,201$3,190,2292,135,082 total
  • Conversion

    8% Convertible Note Issued 12/2/2014

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 9/9/2013

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 2/26/14

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Purchase

    Common Stock

    2015-01-30$11.00/sh+23,457$258,0272,158,539 total
Transactions
  • Conversion

    Common Stock

    2015-01-30$9.35/sh+341,201$3,190,2292,135,082 total
  • Conversion

    8% Convertible Note Issued 9/9/2013

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 2/26/14

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 12/2/2014

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Purchase

    Common Stock

    2015-01-30$11.00/sh+23,457$258,0272,158,539 total
Transactions
  • Conversion

    Common Stock

    2015-01-30$9.35/sh+341,201$3,190,2292,135,082 total
  • Conversion

    8% Convertible Note Issued 9/9/2013

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Purchase

    Common Stock

    2015-01-30$11.00/sh+23,457$258,0272,158,539 total
  • Conversion

    8% Convertible Note Issued 2/26/14

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 12/2/2014

    2015-01-30
    Exp: 2015-03-31Common Stock
Transactions
  • Conversion

    Common Stock

    2015-01-30$9.35/sh+341,201$3,190,2292,135,082 total
  • Conversion

    8% Convertible Note Issued 9/9/2013

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Purchase

    Common Stock

    2015-01-30$11.00/sh+23,457$258,0272,158,539 total
  • Conversion

    8% Convertible Note Issued 2/26/14

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 12/2/2014

    2015-01-30
    Exp: 2015-03-31Common Stock
DRANT RYAN D
10% Owner
Transactions
  • Conversion

    Common Stock

    2015-01-30$9.35/sh+341,201$3,190,2292,135,082 total
  • Conversion

    8% Convertible Note Issued 9/9/2013

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Purchase

    Common Stock

    2015-01-30$11.00/sh+23,457$258,0272,158,539 total
  • Conversion

    8% Convertible Note Issued 2/26/14

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 12/2/2014

    2015-01-30
    Exp: 2015-03-31Common Stock
Transactions
  • Conversion

    8% Convertible Note Issued 9/9/2013

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 12/2/2014

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Purchase

    Common Stock

    2015-01-30$11.00/sh+23,457$258,0272,158,539 total
  • Conversion

    Common Stock

    2015-01-30$9.35/sh+341,201$3,190,2292,135,082 total
  • Conversion

    8% Convertible Note Issued 2/26/14

    2015-01-30
    Exp: 2015-03-31Common Stock
Transactions
  • Conversion

    8% Convertible Note Issued 9/9/2013

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    Common Stock

    2015-01-30$9.35/sh+341,201$3,190,2292,135,082 total
  • Conversion

    8% Convertible Note Issued 2/26/14

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Purchase

    Common Stock

    2015-01-30$11.00/sh+23,457$258,0272,158,539 total
  • Conversion

    8% Convertible Note Issued 12/2/2014

    2015-01-30
    Exp: 2015-03-31Common Stock
Transactions
  • Conversion

    8% Convertible Note Issued 9/9/2013

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 12/2/2014

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    Common Stock

    2015-01-30$9.35/sh+341,201$3,190,2292,135,082 total
  • Purchase

    Common Stock

    2015-01-30$11.00/sh+23,457$258,0272,158,539 total
  • Conversion

    8% Convertible Note Issued 2/26/14

    2015-01-30
    Exp: 2015-03-31Common Stock
Transactions
  • Conversion

    8% Convertible Note Issued 2/26/14

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    Common Stock

    2015-01-30$9.35/sh+341,201$3,190,2292,135,082 total
  • Purchase

    Common Stock

    2015-01-30$11.00/sh+23,457$258,0272,158,539 total
  • Conversion

    8% Convertible Note Issued 9/9/2013

    2015-01-30
    Exp: 2015-03-31Common Stock
  • Conversion

    8% Convertible Note Issued 12/2/2014

    2015-01-30
    Exp: 2015-03-31Common Stock
Footnotes (2)
  • [F1]The outstanding principal and accrued interest on the Convertible Notes automatically converted into shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering at 85% of the Issuer's initial public offering price per share.
  • [F2]The securities are directly held by New Enterprise Associates 12, Limited Partnership ("NEA 12") and indirectly held by NEA Partners 12, Limited Partnership ("NEA Partners 12"), the sole general partner of NEA 12, NEA 12 GP, LLC ("NEA 12 GP"), the sole general partner of NEA Partners 12, and the individual managers of NEA 12 GP (NEA Partners 12, NEA 12 GP and the individual managers of NEA 12 GP together, the "NEA 12 Indirect Reporting Persons"). The individual managers of NEA 12 GP are M. James Barrett, Peter J. Barris, Forest Baskett, Ryan D. Drant, Patrick J. Kerins, Krishna "Kittu" Kolluri, and Scott D. Sandell. The NEA 12 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 12 shares in which the NEA 12 Indirect Reporting Persons have no pecuniary interest.

Documents

1 file

Issuer

Zosano Pharma Corp

CIK 0001587221

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001587221

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 1:32 PM ET
Size
22.9 KB